A study of 2,035 MPN patients (PMF 184; PV 411; ET 577) showed that the cohort harboring NF-E2 mutations frequently was JAK2V617F homozygous, and NF-E2 mutations were acquired significantly later in the disease course [25]. Here, NFE2 is linked to myeloproliferative neoplasm.